Skip to main content
. 2021 Sep 28;21:233. doi: 10.1186/s12871-021-01452-0

Table 3.

Summary of findings

Quality assessment Summary of findings
Outcome Limitations Inconsistency Indirectness Imprecision Publication Bias Number of
Patients in
DEX Group
Number of Patients in Control Group Mean Difference or Relative Risk
(95% CI)
P Value for Overall Effect Quality of Evidence (GRADE)
DOA when combined with short−/intermediate-acting LA (min) Concealment not clear in most studies Serious inconsistency Moderate indirectness No serious imprecision 7 studies missing for our primary outcome 140 135 126.01(44.22 to 207.81) 0.003 Very low quality
DOA when combined with long-acting LA (min) Concealment not clear in most studies Serious inconsistency Moderate indirectness No serious imprecision 7 studies missing for our primary outcome 1411 1402 305.52(271.81 to 339.22) <0.00001 Very low quality
Pain score at rest at 12 h postoperatively (analog scale, 0–10) Concealment not clear in most studies Serious inconsistency No serious indirectness Moderate imprecision 7 studies missing for our primary outcome 346 341 −1.57(−1.91 to −1.23) <0.00001 Very low quality
Pain score at rest at 24 h postoperatively (analog scale, 0–10) Concealment not clear in most studies Serious inconsistency No serious indirectness Moderate imprecision 7 studies missing for our primary outcome 321 314 −0.60(−1.61 to 0.42) 0.25 Very low quality
Cumulative IV morphine consumption at 24 h postoperatively (mg) Concealment not clear in most studies Serious inconsistency No serious indirectness Moderate imprecision 7 studies missing for our primary outcome 256 250 −5.03(−7.54 to −2.51) <0.0001 Very low quality
Rate of bradycardia 28 of 57 trials reported that outcome Serious inconsistency No serious indirectness Serious imprecision 7 studies missing for our primary outcome 862 852 0.13(0.06 to 0.20) 0.0002 Very low quality
Rate of hypotension 26 of 57 trials reported that outcome Serious inconsistency No serious indirectness Serious imprecision 7 studies missing for our primary outcome 802 789 0.05(0.01 to 0.09) 0.007 Very low quality

Abbreviations: DEX, dexmedetomidine; CI, confidence interval; GRADE, Grades of Recommendation, Assessment, Development, and Evaluation; DOA, duration of analgesia; LA, local anesthetic; IV, intravenous